BMC Cancer

official impact factor 3.15

Open Access Highly Access Research article

Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib

Marius Horger, Ulrich M Lauer, Christina Schraml, Christoph P Berg, Ursula Koppenhöfer, Claus D Claussen, Michael Gregor and Michael Bitzer*

BMC Cancer 2009, 9:208 doi:10.1186/1471-2407-9-208

No comments have yet been made on this article.

Post a comment